U

United Laboratories International Holdings Ltd
HKEX:3933

Watchlist Manager
United Laboratories International Holdings Ltd
HKEX:3933
Watchlist
Price: 10.26 HKD 1.38%
Market Cap: 18.6B HKD
Have any thoughts about
United Laboratories International Holdings Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
United Laboratories International Holdings Ltd

Wall Street analysts forecast United Laboratories International Holdings Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for United Laboratories International Holdings Ltd is 12.94 HKD with a low forecast of 9.4 HKD and a high forecast of 23.1 HKD.

Lowest
Price Target
9.4 HKD
8% Downside
Average
Price Target
12.94 HKD
26% Upside
Highest
Price Target
23.1 HKD
125% Upside
United Laboratories International Holdings Ltd Competitors:
Price Targets
600062
China Resources Double-Crane Pharmaceutical Co Ltd
21% Upside
SUNPHARMA
Sun Pharmaceutical Industries Ltd
6% Upside
VIRP
Virbac SA
23% Upside
326030
SK Biopharmaceuticals Co Ltd
11% Upside
600085
Beijing Tongrentang Co Ltd
20% Upside
2070
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC
25% Upside
BTMD
biote Corp
49% Upside
600200
JiangSu WuZhong Pharmaceutical Development Co Ltd
30% Upside

Revenue
Forecast

Revenue Estimate
United Laboratories International Holdings Ltd

For the last 8 years the compound annual growth rate for United Laboratories International Holdings Ltd's revenue is 9%. The projected CAGR for the next 3 years is 6%.

9%
Past Growth
6%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
United Laboratories International Holdings Ltd

For the last 8 years the compound annual growth rate for United Laboratories International Holdings Ltd's operating income is 20%. The projected CAGR for the next 3 years is 4%.

20%
Past Growth
4%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
United Laboratories International Holdings Ltd

For the last 8 years the compound annual growth rate for United Laboratories International Holdings Ltd's net income is 52%. The projected CAGR for the next 3 years is 7%.

52%
Past Growth
7%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is United Laboratories International Holdings Ltd's stock price target?
Price Target
12.94 HKD

According to Wall Street analysts, the average 1-year price target for United Laboratories International Holdings Ltd is 12.94 HKD with a low forecast of 9.4 HKD and a high forecast of 23.1 HKD.

What is United Laboratories International Holdings Ltd's Revenue forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for United Laboratories International Holdings Ltd's revenue is 9%. The projected CAGR for the next 3 years is 6%.

What is United Laboratories International Holdings Ltd's Operating Income forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for United Laboratories International Holdings Ltd's operating income is 20%. The projected CAGR for the next 3 years is 4%.

What is United Laboratories International Holdings Ltd's Net Income forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for United Laboratories International Holdings Ltd's net income is 52%. The projected CAGR for the next 3 years is 7%.

Back to Top